{"id":"NCT00766493","sponsor":"W.L.Gore & Associates","briefTitle":"GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)","officialTitle":"GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (GORE EMBOLDEN)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-01","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2008-10-06","resultsPosted":"2012-08-07","lastUpdate":"2016-09-29"},"enrollment":250,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Carotid Artery Stenosis"],"interventions":[{"type":"DEVICE","name":"GORE® Embolic Filter","otherNames":[]}],"arms":[{"label":"GORE® Embolic Filter","type":"EXPERIMENTAL"}],"summary":"Compare the 30-day safety and efficacy of the GORE® Embolic Filter used in conjunction with FDA-approved carotid stents to a performance goal obtained from carotid stent studies utilizing distal embolic protection.","primaryOutcome":{"measure":"Composite Major Adverse Event (MAE) Rate of Death, Myocardial Infarction, and Stroke at 30 Days Postprocedure","timeFrame":"30 days","effectByArm":[{"arm":"EMBOLDEN","deltaMin":10,"sd":null}],"pValues":[{"comp":"OG000","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":7},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":56,"n":250},"commonTop":["Hypotension","Hypertension","Anemia","Nervous System - Other","Nausea"]}}